MSI as a biomarker in gynecological cancer
Microsatellite instability (MSI) in tumors is a known predictor of response to certain therapies in gynecological cancer. In this video, Alexandra Leary, MD, PhD, of the Gustave Roussy Institute of On...
Author: VJOncology
Added: 06/22/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology